nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A5—prostate cancer	0.235	0.698	CbGaD
Lercanidipine—CYP3A4—prostate cancer	0.102	0.302	CbGaD
Lercanidipine—CYP3A5—Flutamide—prostate cancer	0.0363	0.0912	CbGbCtD
Lercanidipine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0325	0.0817	CbGbCtD
Lercanidipine—CYP2D6—Bicalutamide—prostate cancer	0.0268	0.0675	CbGbCtD
Lercanidipine—CYP3A5—Cabazitaxel—prostate cancer	0.0268	0.0675	CbGbCtD
Lercanidipine—CYP3A5—Estrone—prostate cancer	0.0262	0.066	CbGbCtD
Lercanidipine—CYP2D6—Abiraterone—prostate cancer	0.0222	0.0559	CbGbCtD
Lercanidipine—CYP3A7—Estradiol—prostate cancer	0.0201	0.0505	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0201	0.0505	CbGbCtD
Lercanidipine—CYP3A4—Bicalutamide—prostate cancer	0.0171	0.0429	CbGbCtD
Lercanidipine—CYP3A4—Estramustine—prostate cancer	0.0159	0.0399	CbGbCtD
Lercanidipine—CYP3A5—Estradiol—prostate cancer	0.0151	0.0379	CbGbCtD
Lercanidipine—CYP3A4—Abiraterone—prostate cancer	0.0141	0.0356	CbGbCtD
Lercanidipine—CYP3A4—Flutamide—prostate cancer	0.0141	0.0356	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.012	0.0302	CbGbCtD
Lercanidipine—CYP3A7—Docetaxel—prostate cancer	0.012	0.0302	CbGbCtD
Lercanidipine—CYP3A4—Cabazitaxel—prostate cancer	0.0105	0.0263	CbGbCtD
Lercanidipine—CYP3A4—Estrone—prostate cancer	0.0102	0.0257	CbGbCtD
Lercanidipine—CYP3A5—Etoposide—prostate cancer	0.00983	0.0247	CbGbCtD
Lercanidipine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00911	0.0229	CbGbCtD
Lercanidipine—CYP3A5—Docetaxel—prostate cancer	0.00899	0.0226	CbGbCtD
Lercanidipine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00669	0.0168	CbGbCtD
Lercanidipine—CYP3A4—Mitoxantrone—prostate cancer	0.00608	0.0153	CbGbCtD
Lercanidipine—CYP3A4—Estradiol—prostate cancer	0.00587	0.0148	CbGbCtD
Lercanidipine—CYP3A4—Prednisone—prostate cancer	0.00505	0.0127	CbGbCtD
Lercanidipine—CYP2D6—Doxorubicin—prostate cancer	0.00411	0.0103	CbGbCtD
Lercanidipine—CYP3A4—Etoposide—prostate cancer	0.00383	0.00965	CbGbCtD
Lercanidipine—CYP3A4—Docetaxel—prostate cancer	0.00351	0.00883	CbGbCtD
Lercanidipine—CYP3A4—Doxorubicin—prostate cancer	0.00261	0.00658	CbGbCtD
Lercanidipine—Nimodipine—AHR—prostate cancer	0.000556	0.144	CrCbGaD
Lercanidipine—Nisoldipine—CYP3A5—prostate cancer	0.000263	0.0684	CrCbGaD
Lercanidipine—Nimodipine—CYP3A5—prostate cancer	0.000254	0.0661	CrCbGaD
Lercanidipine—Nitrendipine—CYP3A5—prostate cancer	0.000246	0.064	CrCbGaD
Lercanidipine—Nilvadipine—CYP2A6—prostate cancer	0.000238	0.0619	CrCbGaD
Lercanidipine—Felodipine—CYP3A5—prostate cancer	0.000196	0.0509	CrCbGaD
Lercanidipine—Nifedipine—CYP3A5—prostate cancer	0.00019	0.0492	CrCbGaD
Lercanidipine—Nicardipine—CYP3A5—prostate cancer	0.000187	0.0485	CrCbGaD
Lercanidipine—Nifedipine—CYP2A6—prostate cancer	0.000183	0.0477	CrCbGaD
Lercanidipine—Nilvadipine—CYP2E1—prostate cancer	0.000169	0.044	CrCbGaD
Lercanidipine—Nilvadipine—CYP2C19—prostate cancer	0.000168	0.0435	CrCbGaD
Lercanidipine—Nifedipine—CYP2E1—prostate cancer	0.00013	0.0338	CrCbGaD
Lercanidipine—Nifedipine—CYP1A1—prostate cancer	0.000129	0.0334	CrCbGaD
Lercanidipine—Nicardipine—CYP2E1—prostate cancer	0.000128	0.0333	CrCbGaD
Lercanidipine—Nicardipine—CYP2C19—prostate cancer	0.000127	0.033	CrCbGaD
Lercanidipine—Nisoldipine—CYP3A4—prostate cancer	0.000114	0.0296	CrCbGaD
Lercanidipine—Nimodipine—CYP3A4—prostate cancer	0.00011	0.0286	CrCbGaD
Lercanidipine—Nitrendipine—CYP3A4—prostate cancer	0.000107	0.0277	CrCbGaD
Lercanidipine—Nilvadipine—CYP3A4—prostate cancer	0.000107	0.0277	CrCbGaD
Lercanidipine—Felodipine—CYP3A4—prostate cancer	8.48e-05	0.022	CrCbGaD
Lercanidipine—Nifedipine—CYP3A4—prostate cancer	8.2e-05	0.0213	CrCbGaD
Lercanidipine—Nicardipine—CYP3A4—prostate cancer	8.08e-05	0.021	CrCbGaD
Lercanidipine—Thrombocytopenia—Capecitabine—prostate cancer	4.69e-05	0.000263	CcSEcCtD
Lercanidipine—Syncope—Prednisone—prostate cancer	4.69e-05	0.000263	CcSEcCtD
Lercanidipine—Tachycardia—Capecitabine—prostate cancer	4.68e-05	0.000263	CcSEcCtD
Lercanidipine—Skin disorder—Capecitabine—prostate cancer	4.65e-05	0.000261	CcSEcCtD
Lercanidipine—Urinary tract disorder—Epirubicin—prostate cancer	4.64e-05	0.000261	CcSEcCtD
Lercanidipine—Hyperhidrosis—Capecitabine—prostate cancer	4.63e-05	0.00026	CcSEcCtD
Lercanidipine—Oedema peripheral—Epirubicin—prostate cancer	4.63e-05	0.00026	CcSEcCtD
Lercanidipine—Hypotension—Docetaxel—prostate cancer	4.62e-05	0.00026	CcSEcCtD
Lercanidipine—Connective tissue disorder—Epirubicin—prostate cancer	4.62e-05	0.000259	CcSEcCtD
Lercanidipine—Urethral disorder—Epirubicin—prostate cancer	4.61e-05	0.000259	CcSEcCtD
Lercanidipine—Loss of consciousness—Prednisone—prostate cancer	4.6e-05	0.000258	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Doxorubicin—prostate cancer	4.58e-05	0.000257	CcSEcCtD
Lercanidipine—Anorexia—Capecitabine—prostate cancer	4.57e-05	0.000256	CcSEcCtD
Lercanidipine—Nausea—Estradiol—prostate cancer	4.56e-05	0.000256	CcSEcCtD
Lercanidipine—Vomiting—Mitoxantrone—prostate cancer	4.55e-05	0.000256	CcSEcCtD
Lercanidipine—Agranulocytosis—Doxorubicin—prostate cancer	4.52e-05	0.000254	CcSEcCtD
Lercanidipine—Rash—Mitoxantrone—prostate cancer	4.51e-05	0.000253	CcSEcCtD
Lercanidipine—Dermatitis—Mitoxantrone—prostate cancer	4.51e-05	0.000253	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.51e-05	0.000253	CcSEcCtD
Lercanidipine—Headache—Mitoxantrone—prostate cancer	4.48e-05	0.000252	CcSEcCtD
Lercanidipine—Hypotension—Capecitabine—prostate cancer	4.48e-05	0.000251	CcSEcCtD
Lercanidipine—Insomnia—Docetaxel—prostate cancer	4.48e-05	0.000251	CcSEcCtD
Lercanidipine—Myalgia—Prednisone—prostate cancer	4.45e-05	0.00025	CcSEcCtD
Lercanidipine—Arthralgia—Prednisone—prostate cancer	4.45e-05	0.00025	CcSEcCtD
Lercanidipine—Paraesthesia—Docetaxel—prostate cancer	4.44e-05	0.00025	CcSEcCtD
Lercanidipine—Erythema multiforme—Epirubicin—prostate cancer	4.44e-05	0.000249	CcSEcCtD
Lercanidipine—Anxiety—Prednisone—prostate cancer	4.44e-05	0.000249	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.42e-05	0.000248	CcSEcCtD
Lercanidipine—Dyspnoea—Docetaxel—prostate cancer	4.41e-05	0.000248	CcSEcCtD
Lercanidipine—Somnolence—Docetaxel—prostate cancer	4.4e-05	0.000247	CcSEcCtD
Lercanidipine—Discomfort—Prednisone—prostate cancer	4.4e-05	0.000247	CcSEcCtD
Lercanidipine—Eye disorder—Epirubicin—prostate cancer	4.39e-05	0.000247	CcSEcCtD
Lercanidipine—Hypersensitivity—Etoposide—prostate cancer	4.39e-05	0.000246	CcSEcCtD
Lercanidipine—Tinnitus—Epirubicin—prostate cancer	4.38e-05	0.000246	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.37e-05	0.000245	CcSEcCtD
Lercanidipine—Cardiac disorder—Epirubicin—prostate cancer	4.36e-05	0.000245	CcSEcCtD
Lercanidipine—Flushing—Epirubicin—prostate cancer	4.36e-05	0.000245	CcSEcCtD
Lercanidipine—Rhinitis—Doxorubicin—prostate cancer	4.36e-05	0.000245	CcSEcCtD
Lercanidipine—Dyspepsia—Docetaxel—prostate cancer	4.36e-05	0.000245	CcSEcCtD
Lercanidipine—Hepatitis—Doxorubicin—prostate cancer	4.35e-05	0.000244	CcSEcCtD
Lercanidipine—Insomnia—Capecitabine—prostate cancer	4.33e-05	0.000243	CcSEcCtD
Lercanidipine—Paraesthesia—Capecitabine—prostate cancer	4.3e-05	0.000242	CcSEcCtD
Lercanidipine—Decreased appetite—Docetaxel—prostate cancer	4.3e-05	0.000242	CcSEcCtD
Lercanidipine—Urinary tract disorder—Doxorubicin—prostate cancer	4.29e-05	0.000241	CcSEcCtD
Lercanidipine—Oedema peripheral—Doxorubicin—prostate cancer	4.28e-05	0.000241	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Docetaxel—prostate cancer	4.27e-05	0.00024	CcSEcCtD
Lercanidipine—Asthenia—Etoposide—prostate cancer	4.27e-05	0.00024	CcSEcCtD
Lercanidipine—Connective tissue disorder—Doxorubicin—prostate cancer	4.27e-05	0.00024	CcSEcCtD
Lercanidipine—Dyspnoea—Capecitabine—prostate cancer	4.27e-05	0.00024	CcSEcCtD
Lercanidipine—Fatigue—Docetaxel—prostate cancer	4.27e-05	0.00024	CcSEcCtD
Lercanidipine—Angiopathy—Epirubicin—prostate cancer	4.26e-05	0.000239	CcSEcCtD
Lercanidipine—Urethral disorder—Doxorubicin—prostate cancer	4.26e-05	0.000239	CcSEcCtD
Lercanidipine—Nausea—Mitoxantrone—prostate cancer	4.25e-05	0.000239	CcSEcCtD
Lercanidipine—Immune system disorder—Epirubicin—prostate cancer	4.24e-05	0.000238	CcSEcCtD
Lercanidipine—Mediastinal disorder—Epirubicin—prostate cancer	4.23e-05	0.000238	CcSEcCtD
Lercanidipine—Constipation—Docetaxel—prostate cancer	4.23e-05	0.000238	CcSEcCtD
Lercanidipine—Dyspepsia—Capecitabine—prostate cancer	4.22e-05	0.000237	CcSEcCtD
Lercanidipine—Pruritus—Etoposide—prostate cancer	4.21e-05	0.000237	CcSEcCtD
Lercanidipine—Shock—Prednisone—prostate cancer	4.2e-05	0.000236	CcSEcCtD
Lercanidipine—Nervous system disorder—Prednisone—prostate cancer	4.19e-05	0.000235	CcSEcCtD
Lercanidipine—Tachycardia—Prednisone—prostate cancer	4.17e-05	0.000234	CcSEcCtD
Lercanidipine—Decreased appetite—Capecitabine—prostate cancer	4.16e-05	0.000234	CcSEcCtD
Lercanidipine—Alopecia—Epirubicin—prostate cancer	4.15e-05	0.000233	CcSEcCtD
Lercanidipine—Skin disorder—Prednisone—prostate cancer	4.15e-05	0.000233	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Capecitabine—prostate cancer	4.14e-05	0.000232	CcSEcCtD
Lercanidipine—Fatigue—Capecitabine—prostate cancer	4.13e-05	0.000232	CcSEcCtD
Lercanidipine—Hyperhidrosis—Prednisone—prostate cancer	4.13e-05	0.000232	CcSEcCtD
Lercanidipine—Mental disorder—Epirubicin—prostate cancer	4.12e-05	0.000231	CcSEcCtD
Lercanidipine—Erythema multiforme—Doxorubicin—prostate cancer	4.11e-05	0.000231	CcSEcCtD
Lercanidipine—Constipation—Capecitabine—prostate cancer	4.1e-05	0.00023	CcSEcCtD
Lercanidipine—Erythema—Epirubicin—prostate cancer	4.09e-05	0.00023	CcSEcCtD
Lercanidipine—Malnutrition—Epirubicin—prostate cancer	4.09e-05	0.00023	CcSEcCtD
Lercanidipine—Feeling abnormal—Docetaxel—prostate cancer	4.08e-05	0.000229	CcSEcCtD
Lercanidipine—Diarrhoea—Etoposide—prostate cancer	4.07e-05	0.000229	CcSEcCtD
Lercanidipine—Anorexia—Prednisone—prostate cancer	4.07e-05	0.000228	CcSEcCtD
Lercanidipine—Eye disorder—Doxorubicin—prostate cancer	4.06e-05	0.000228	CcSEcCtD
Lercanidipine—Tinnitus—Doxorubicin—prostate cancer	4.05e-05	0.000228	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Docetaxel—prostate cancer	4.05e-05	0.000227	CcSEcCtD
Lercanidipine—Cardiac disorder—Doxorubicin—prostate cancer	4.03e-05	0.000227	CcSEcCtD
Lercanidipine—Flushing—Doxorubicin—prostate cancer	4.03e-05	0.000227	CcSEcCtD
Lercanidipine—Tension—Epirubicin—prostate cancer	4.01e-05	0.000225	CcSEcCtD
Lercanidipine—Dysgeusia—Epirubicin—prostate cancer	4e-05	0.000225	CcSEcCtD
Lercanidipine—Nervousness—Epirubicin—prostate cancer	3.97e-05	0.000223	CcSEcCtD
Lercanidipine—Feeling abnormal—Capecitabine—prostate cancer	3.95e-05	0.000222	CcSEcCtD
Lercanidipine—Angiopathy—Doxorubicin—prostate cancer	3.94e-05	0.000222	CcSEcCtD
Lercanidipine—Dizziness—Etoposide—prostate cancer	3.94e-05	0.000221	CcSEcCtD
Lercanidipine—Muscle spasms—Epirubicin—prostate cancer	3.93e-05	0.000221	CcSEcCtD
Lercanidipine—Immune system disorder—Doxorubicin—prostate cancer	3.93e-05	0.000221	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Capecitabine—prostate cancer	3.92e-05	0.00022	CcSEcCtD
Lercanidipine—Mediastinal disorder—Doxorubicin—prostate cancer	3.92e-05	0.00022	CcSEcCtD
Lercanidipine—Abdominal pain—Docetaxel—prostate cancer	3.91e-05	0.00022	CcSEcCtD
Lercanidipine—Body temperature increased—Docetaxel—prostate cancer	3.91e-05	0.00022	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Prednisone—prostate cancer	3.89e-05	0.000218	CcSEcCtD
Lercanidipine—Insomnia—Prednisone—prostate cancer	3.86e-05	0.000217	CcSEcCtD
Lercanidipine—Vision blurred—Epirubicin—prostate cancer	3.85e-05	0.000216	CcSEcCtD
Lercanidipine—Alopecia—Doxorubicin—prostate cancer	3.84e-05	0.000216	CcSEcCtD
Lercanidipine—Paraesthesia—Prednisone—prostate cancer	3.83e-05	0.000215	CcSEcCtD
Lercanidipine—Mental disorder—Doxorubicin—prostate cancer	3.81e-05	0.000214	CcSEcCtD
Lercanidipine—Urticaria—Capecitabine—prostate cancer	3.81e-05	0.000214	CcSEcCtD
Lercanidipine—Ill-defined disorder—Epirubicin—prostate cancer	3.79e-05	0.000213	CcSEcCtD
Lercanidipine—Abdominal pain—Capecitabine—prostate cancer	3.79e-05	0.000213	CcSEcCtD
Lercanidipine—Body temperature increased—Capecitabine—prostate cancer	3.79e-05	0.000213	CcSEcCtD
Lercanidipine—Vomiting—Etoposide—prostate cancer	3.79e-05	0.000213	CcSEcCtD
Lercanidipine—Erythema—Doxorubicin—prostate cancer	3.78e-05	0.000213	CcSEcCtD
Lercanidipine—Malnutrition—Doxorubicin—prostate cancer	3.78e-05	0.000213	CcSEcCtD
Lercanidipine—Anaemia—Epirubicin—prostate cancer	3.78e-05	0.000212	CcSEcCtD
Lercanidipine—Dyspepsia—Prednisone—prostate cancer	3.76e-05	0.000211	CcSEcCtD
Lercanidipine—Rash—Etoposide—prostate cancer	3.75e-05	0.000211	CcSEcCtD
Lercanidipine—Dermatitis—Etoposide—prostate cancer	3.75e-05	0.000211	CcSEcCtD
Lercanidipine—Headache—Etoposide—prostate cancer	3.73e-05	0.00021	CcSEcCtD
Lercanidipine—Tension—Doxorubicin—prostate cancer	3.71e-05	0.000209	CcSEcCtD
Lercanidipine—Decreased appetite—Prednisone—prostate cancer	3.71e-05	0.000208	CcSEcCtD
Lercanidipine—Dysgeusia—Doxorubicin—prostate cancer	3.71e-05	0.000208	CcSEcCtD
Lercanidipine—Malaise—Epirubicin—prostate cancer	3.69e-05	0.000207	CcSEcCtD
Lercanidipine—Fatigue—Prednisone—prostate cancer	3.68e-05	0.000207	CcSEcCtD
Lercanidipine—Nervousness—Doxorubicin—prostate cancer	3.68e-05	0.000206	CcSEcCtD
Lercanidipine—Vertigo—Epirubicin—prostate cancer	3.67e-05	0.000206	CcSEcCtD
Lercanidipine—Syncope—Epirubicin—prostate cancer	3.67e-05	0.000206	CcSEcCtD
Lercanidipine—Constipation—Prednisone—prostate cancer	3.65e-05	0.000205	CcSEcCtD
Lercanidipine—Hypersensitivity—Docetaxel—prostate cancer	3.65e-05	0.000205	CcSEcCtD
Lercanidipine—Muscle spasms—Doxorubicin—prostate cancer	3.64e-05	0.000204	CcSEcCtD
Lercanidipine—Palpitations—Epirubicin—prostate cancer	3.61e-05	0.000203	CcSEcCtD
Lercanidipine—Loss of consciousness—Epirubicin—prostate cancer	3.59e-05	0.000202	CcSEcCtD
Lercanidipine—Cough—Epirubicin—prostate cancer	3.57e-05	0.0002	CcSEcCtD
Lercanidipine—Vision blurred—Doxorubicin—prostate cancer	3.57e-05	0.0002	CcSEcCtD
Lercanidipine—Asthenia—Docetaxel—prostate cancer	3.55e-05	0.000199	CcSEcCtD
Lercanidipine—Nausea—Etoposide—prostate cancer	3.54e-05	0.000199	CcSEcCtD
Lercanidipine—Hypersensitivity—Capecitabine—prostate cancer	3.53e-05	0.000198	CcSEcCtD
Lercanidipine—Feeling abnormal—Prednisone—prostate cancer	3.52e-05	0.000198	CcSEcCtD
Lercanidipine—Ill-defined disorder—Doxorubicin—prostate cancer	3.51e-05	0.000197	CcSEcCtD
Lercanidipine—Pruritus—Docetaxel—prostate cancer	3.5e-05	0.000197	CcSEcCtD
Lercanidipine—Anaemia—Doxorubicin—prostate cancer	3.5e-05	0.000196	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Prednisone—prostate cancer	3.49e-05	0.000196	CcSEcCtD
Lercanidipine—Chest pain—Epirubicin—prostate cancer	3.48e-05	0.000196	CcSEcCtD
Lercanidipine—Arthralgia—Epirubicin—prostate cancer	3.48e-05	0.000196	CcSEcCtD
Lercanidipine—Myalgia—Epirubicin—prostate cancer	3.48e-05	0.000196	CcSEcCtD
Lercanidipine—Anxiety—Epirubicin—prostate cancer	3.47e-05	0.000195	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.46e-05	0.000194	CcSEcCtD
Lercanidipine—Discomfort—Epirubicin—prostate cancer	3.44e-05	0.000193	CcSEcCtD
Lercanidipine—Asthenia—Capecitabine—prostate cancer	3.44e-05	0.000193	CcSEcCtD
Lercanidipine—Malaise—Doxorubicin—prostate cancer	3.41e-05	0.000192	CcSEcCtD
Lercanidipine—Dry mouth—Epirubicin—prostate cancer	3.41e-05	0.000191	CcSEcCtD
Lercanidipine—Vertigo—Doxorubicin—prostate cancer	3.4e-05	0.000191	CcSEcCtD
Lercanidipine—Syncope—Doxorubicin—prostate cancer	3.39e-05	0.000191	CcSEcCtD
Lercanidipine—Urticaria—Prednisone—prostate cancer	3.39e-05	0.00019	CcSEcCtD
Lercanidipine—Pruritus—Capecitabine—prostate cancer	3.39e-05	0.00019	CcSEcCtD
Lercanidipine—Diarrhoea—Docetaxel—prostate cancer	3.39e-05	0.00019	CcSEcCtD
Lercanidipine—Abdominal pain—Prednisone—prostate cancer	3.37e-05	0.000189	CcSEcCtD
Lercanidipine—Body temperature increased—Prednisone—prostate cancer	3.37e-05	0.000189	CcSEcCtD
Lercanidipine—Confusional state—Epirubicin—prostate cancer	3.37e-05	0.000189	CcSEcCtD
Lercanidipine—Palpitations—Doxorubicin—prostate cancer	3.34e-05	0.000188	CcSEcCtD
Lercanidipine—Loss of consciousness—Doxorubicin—prostate cancer	3.33e-05	0.000187	CcSEcCtD
Lercanidipine—Cough—Doxorubicin—prostate cancer	3.3e-05	0.000185	CcSEcCtD
Lercanidipine—Shock—Epirubicin—prostate cancer	3.28e-05	0.000184	CcSEcCtD
Lercanidipine—Diarrhoea—Capecitabine—prostate cancer	3.28e-05	0.000184	CcSEcCtD
Lercanidipine—Nervous system disorder—Epirubicin—prostate cancer	3.27e-05	0.000184	CcSEcCtD
Lercanidipine—Dizziness—Docetaxel—prostate cancer	3.27e-05	0.000184	CcSEcCtD
Lercanidipine—Thrombocytopenia—Epirubicin—prostate cancer	3.27e-05	0.000184	CcSEcCtD
Lercanidipine—Tachycardia—Epirubicin—prostate cancer	3.26e-05	0.000183	CcSEcCtD
Lercanidipine—Skin disorder—Epirubicin—prostate cancer	3.24e-05	0.000182	CcSEcCtD
Lercanidipine—Hyperhidrosis—Epirubicin—prostate cancer	3.23e-05	0.000181	CcSEcCtD
Lercanidipine—Chest pain—Doxorubicin—prostate cancer	3.22e-05	0.000181	CcSEcCtD
Lercanidipine—Myalgia—Doxorubicin—prostate cancer	3.22e-05	0.000181	CcSEcCtD
Lercanidipine—Arthralgia—Doxorubicin—prostate cancer	3.22e-05	0.000181	CcSEcCtD
Lercanidipine—Anxiety—Doxorubicin—prostate cancer	3.21e-05	0.00018	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.2e-05	0.00018	CcSEcCtD
Lercanidipine—Discomfort—Doxorubicin—prostate cancer	3.18e-05	0.000179	CcSEcCtD
Lercanidipine—Anorexia—Epirubicin—prostate cancer	3.18e-05	0.000179	CcSEcCtD
Lercanidipine—Dizziness—Capecitabine—prostate cancer	3.17e-05	0.000178	CcSEcCtD
Lercanidipine—Dry mouth—Doxorubicin—prostate cancer	3.15e-05	0.000177	CcSEcCtD
Lercanidipine—Vomiting—Docetaxel—prostate cancer	3.15e-05	0.000177	CcSEcCtD
Lercanidipine—Hypersensitivity—Prednisone—prostate cancer	3.14e-05	0.000177	CcSEcCtD
Lercanidipine—Rash—Docetaxel—prostate cancer	3.12e-05	0.000175	CcSEcCtD
Lercanidipine—Hypotension—Epirubicin—prostate cancer	3.12e-05	0.000175	CcSEcCtD
Lercanidipine—Dermatitis—Docetaxel—prostate cancer	3.12e-05	0.000175	CcSEcCtD
Lercanidipine—Confusional state—Doxorubicin—prostate cancer	3.11e-05	0.000175	CcSEcCtD
Lercanidipine—Headache—Docetaxel—prostate cancer	3.1e-05	0.000174	CcSEcCtD
Lercanidipine—Asthenia—Prednisone—prostate cancer	3.06e-05	0.000172	CcSEcCtD
Lercanidipine—Vomiting—Capecitabine—prostate cancer	3.05e-05	0.000171	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.04e-05	0.000171	CcSEcCtD
Lercanidipine—Shock—Doxorubicin—prostate cancer	3.04e-05	0.000171	CcSEcCtD
Lercanidipine—Nervous system disorder—Doxorubicin—prostate cancer	3.03e-05	0.00017	CcSEcCtD
Lercanidipine—Thrombocytopenia—Doxorubicin—prostate cancer	3.02e-05	0.00017	CcSEcCtD
Lercanidipine—Rash—Capecitabine—prostate cancer	3.02e-05	0.00017	CcSEcCtD
Lercanidipine—Pruritus—Prednisone—prostate cancer	3.02e-05	0.00017	CcSEcCtD
Lercanidipine—Insomnia—Epirubicin—prostate cancer	3.02e-05	0.00017	CcSEcCtD
Lercanidipine—Dermatitis—Capecitabine—prostate cancer	3.02e-05	0.00017	CcSEcCtD
Lercanidipine—Tachycardia—Doxorubicin—prostate cancer	3.01e-05	0.000169	CcSEcCtD
Lercanidipine—Headache—Capecitabine—prostate cancer	3e-05	0.000169	CcSEcCtD
Lercanidipine—Skin disorder—Doxorubicin—prostate cancer	3e-05	0.000168	CcSEcCtD
Lercanidipine—Paraesthesia—Epirubicin—prostate cancer	3e-05	0.000168	CcSEcCtD
Lercanidipine—Hyperhidrosis—Doxorubicin—prostate cancer	2.99e-05	0.000168	CcSEcCtD
Lercanidipine—Dyspnoea—Epirubicin—prostate cancer	2.98e-05	0.000167	CcSEcCtD
Lercanidipine—Somnolence—Epirubicin—prostate cancer	2.97e-05	0.000167	CcSEcCtD
Lercanidipine—Anorexia—Doxorubicin—prostate cancer	2.94e-05	0.000165	CcSEcCtD
Lercanidipine—Nausea—Docetaxel—prostate cancer	2.94e-05	0.000165	CcSEcCtD
Lercanidipine—Dyspepsia—Epirubicin—prostate cancer	2.94e-05	0.000165	CcSEcCtD
Lercanidipine—Diarrhoea—Prednisone—prostate cancer	2.92e-05	0.000164	CcSEcCtD
Lercanidipine—Decreased appetite—Epirubicin—prostate cancer	2.9e-05	0.000163	CcSEcCtD
Lercanidipine—Hypotension—Doxorubicin—prostate cancer	2.89e-05	0.000162	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Epirubicin—prostate cancer	2.88e-05	0.000162	CcSEcCtD
Lercanidipine—Fatigue—Epirubicin—prostate cancer	2.88e-05	0.000162	CcSEcCtD
Lercanidipine—Constipation—Epirubicin—prostate cancer	2.85e-05	0.00016	CcSEcCtD
Lercanidipine—Nausea—Capecitabine—prostate cancer	2.85e-05	0.00016	CcSEcCtD
Lercanidipine—Dizziness—Prednisone—prostate cancer	2.82e-05	0.000158	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.81e-05	0.000158	CcSEcCtD
Lercanidipine—Insomnia—Doxorubicin—prostate cancer	2.79e-05	0.000157	CcSEcCtD
Lercanidipine—Paraesthesia—Doxorubicin—prostate cancer	2.77e-05	0.000156	CcSEcCtD
Lercanidipine—Dyspnoea—Doxorubicin—prostate cancer	2.75e-05	0.000155	CcSEcCtD
Lercanidipine—Feeling abnormal—Epirubicin—prostate cancer	2.75e-05	0.000154	CcSEcCtD
Lercanidipine—Somnolence—Doxorubicin—prostate cancer	2.75e-05	0.000154	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Epirubicin—prostate cancer	2.73e-05	0.000153	CcSEcCtD
Lercanidipine—Dyspepsia—Doxorubicin—prostate cancer	2.72e-05	0.000153	CcSEcCtD
Lercanidipine—Vomiting—Prednisone—prostate cancer	2.71e-05	0.000152	CcSEcCtD
Lercanidipine—Rash—Prednisone—prostate cancer	2.69e-05	0.000151	CcSEcCtD
Lercanidipine—Dermatitis—Prednisone—prostate cancer	2.69e-05	0.000151	CcSEcCtD
Lercanidipine—Decreased appetite—Doxorubicin—prostate cancer	2.68e-05	0.000151	CcSEcCtD
Lercanidipine—Headache—Prednisone—prostate cancer	2.67e-05	0.00015	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.67e-05	0.00015	CcSEcCtD
Lercanidipine—Fatigue—Doxorubicin—prostate cancer	2.66e-05	0.00015	CcSEcCtD
Lercanidipine—Urticaria—Epirubicin—prostate cancer	2.65e-05	0.000149	CcSEcCtD
Lercanidipine—Constipation—Doxorubicin—prostate cancer	2.64e-05	0.000148	CcSEcCtD
Lercanidipine—Abdominal pain—Epirubicin—prostate cancer	2.64e-05	0.000148	CcSEcCtD
Lercanidipine—Body temperature increased—Epirubicin—prostate cancer	2.64e-05	0.000148	CcSEcCtD
Lercanidipine—Feeling abnormal—Doxorubicin—prostate cancer	2.54e-05	0.000143	CcSEcCtD
Lercanidipine—Nausea—Prednisone—prostate cancer	2.53e-05	0.000142	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Doxorubicin—prostate cancer	2.53e-05	0.000142	CcSEcCtD
Lercanidipine—Hypersensitivity—Epirubicin—prostate cancer	2.46e-05	0.000138	CcSEcCtD
Lercanidipine—Urticaria—Doxorubicin—prostate cancer	2.45e-05	0.000138	CcSEcCtD
Lercanidipine—Abdominal pain—Doxorubicin—prostate cancer	2.44e-05	0.000137	CcSEcCtD
Lercanidipine—Body temperature increased—Doxorubicin—prostate cancer	2.44e-05	0.000137	CcSEcCtD
Lercanidipine—Asthenia—Epirubicin—prostate cancer	2.39e-05	0.000134	CcSEcCtD
Lercanidipine—Pruritus—Epirubicin—prostate cancer	2.36e-05	0.000133	CcSEcCtD
Lercanidipine—Diarrhoea—Epirubicin—prostate cancer	2.28e-05	0.000128	CcSEcCtD
Lercanidipine—Hypersensitivity—Doxorubicin—prostate cancer	2.28e-05	0.000128	CcSEcCtD
Lercanidipine—Asthenia—Doxorubicin—prostate cancer	2.22e-05	0.000124	CcSEcCtD
Lercanidipine—Dizziness—Epirubicin—prostate cancer	2.21e-05	0.000124	CcSEcCtD
Lercanidipine—Pruritus—Doxorubicin—prostate cancer	2.18e-05	0.000123	CcSEcCtD
Lercanidipine—Vomiting—Epirubicin—prostate cancer	2.12e-05	0.000119	CcSEcCtD
Lercanidipine—Diarrhoea—Doxorubicin—prostate cancer	2.11e-05	0.000119	CcSEcCtD
Lercanidipine—Rash—Epirubicin—prostate cancer	2.1e-05	0.000118	CcSEcCtD
Lercanidipine—Dermatitis—Epirubicin—prostate cancer	2.1e-05	0.000118	CcSEcCtD
Lercanidipine—Headache—Epirubicin—prostate cancer	2.09e-05	0.000117	CcSEcCtD
Lercanidipine—Dizziness—Doxorubicin—prostate cancer	2.04e-05	0.000115	CcSEcCtD
Lercanidipine—Nausea—Epirubicin—prostate cancer	1.98e-05	0.000111	CcSEcCtD
Lercanidipine—Vomiting—Doxorubicin—prostate cancer	1.96e-05	0.00011	CcSEcCtD
Lercanidipine—Rash—Doxorubicin—prostate cancer	1.95e-05	0.000109	CcSEcCtD
Lercanidipine—Dermatitis—Doxorubicin—prostate cancer	1.95e-05	0.000109	CcSEcCtD
Lercanidipine—Headache—Doxorubicin—prostate cancer	1.93e-05	0.000109	CcSEcCtD
Lercanidipine—Nausea—Doxorubicin—prostate cancer	1.83e-05	0.000103	CcSEcCtD
Lercanidipine—CYP3A4—Metabolism—PGAM2—prostate cancer	7.92e-06	9.39e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—INS—prostate cancer	7.89e-06	9.36e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NQO1—prostate cancer	7.88e-06	9.35e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SULT2A1—prostate cancer	7.88e-06	9.35e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—LDHB—prostate cancer	7.8e-06	9.26e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—TH—prostate cancer	7.77e-06	9.22e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—MED12—prostate cancer	7.76e-06	9.2e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CREBBP—prostate cancer	7.73e-06	9.17e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GNG5—prostate cancer	7.69e-06	9.13e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP3A4—prostate cancer	7.69e-06	9.12e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP3A5—prostate cancer	7.66e-06	9.09e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—IL6—prostate cancer	7.62e-06	9.04e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP1B1—prostate cancer	7.56e-06	8.97e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—AMACR—prostate cancer	7.5e-06	8.9e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP3A43—prostate cancer	7.5e-06	8.9e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SRD5A2—prostate cancer	7.5e-06	8.9e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NAT1—prostate cancer	7.5e-06	8.9e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—DEGS1—prostate cancer	7.5e-06	8.9e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NCOA3—prostate cancer	7.41e-06	8.79e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—UCP3—prostate cancer	7.4e-06	8.77e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TCN2—prostate cancer	7.4e-06	8.77e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTA3—prostate cancer	7.4e-06	8.77e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PDHA1—prostate cancer	7.4e-06	8.77e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3CD—prostate cancer	7.33e-06	8.7e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CG—prostate cancer	7.33e-06	8.69e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GGT1—prostate cancer	7.32e-06	8.68e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NCOA1—prostate cancer	7.21e-06	8.55e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HSD17B1—prostate cancer	7.16e-06	8.49e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP19A1—prostate cancer	7.11e-06	8.43e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—HPGDS—prostate cancer	7.07e-06	8.39e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLC22A3—prostate cancer	7.06e-06	8.37e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—HSD3B1—prostate cancer	7.06e-06	8.37e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—AKT1—prostate cancer	7.03e-06	8.34e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP2C19—prostate cancer	7.03e-06	8.34e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—INS—prostate cancer	6.94e-06	8.23e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—NOS3—prostate cancer	6.92e-06	8.21e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—RXRA—prostate cancer	6.86e-06	8.14e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTT1—prostate cancer	6.86e-06	8.14e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ACHE—prostate cancer	6.86e-06	8.14e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CREBBP—prostate cancer	6.79e-06	8.06e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP2A6—prostate cancer	6.78e-06	8.04e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTA4—prostate cancer	6.77e-06	8.03e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TBXAS1—prostate cancer	6.77e-06	8.03e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—COMT—prostate cancer	6.61e-06	7.84e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—AKR1C3—prostate cancer	6.59e-06	7.82e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTA2—prostate cancer	6.59e-06	7.82e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTP1—prostate cancer	6.58e-06	7.8e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PRKACB—prostate cancer	6.56e-06	7.78e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SULT1A1—prostate cancer	6.51e-06	7.72e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ABCG5—prostate cancer	6.51e-06	7.72e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP17A1—prostate cancer	6.49e-06	7.7e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ITPR1—prostate cancer	6.47e-06	7.68e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CD—prostate cancer	6.44e-06	7.64e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3CB—prostate cancer	6.39e-06	7.58e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HPGD—prostate cancer	6.38e-06	7.57e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—B4GALT4—prostate cancer	6.38e-06	7.57e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTA1—prostate cancer	6.36e-06	7.55e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTGS2—prostate cancer	6.33e-06	7.51e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NAT2—prostate cancer	6.29e-06	7.46e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTO1—prostate cancer	6.29e-06	7.46e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—HSD3B2—prostate cancer	6.29e-06	7.46e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NCOA2—prostate cancer	6.19e-06	7.34e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—TYMS—prostate cancer	6.11e-06	7.25e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—NOS3—prostate cancer	6.08e-06	7.22e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTM1—prostate cancer	6.04e-06	7.17e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PLCB2—prostate cancer	6.03e-06	7.15e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP2C18—prostate cancer	6.03e-06	7.15e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—LRP2—prostate cancer	6.03e-06	7.15e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	6e-06	7.12e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—LPL—prostate cancer	5.93e-06	7.04e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—P4HB—prostate cancer	5.91e-06	7.01e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SLC5A5—prostate cancer	5.9e-06	7e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP7B1—prostate cancer	5.84e-06	6.92e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—MTAP—prostate cancer	5.84e-06	6.92e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP2E1—prostate cancer	5.76e-06	6.84e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLC22A1—prostate cancer	5.75e-06	6.82e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP1A1—prostate cancer	5.73e-06	6.8e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NQO1—prostate cancer	5.7e-06	6.76e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SULT1E1—prostate cancer	5.69e-06	6.75e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SRD5A1—prostate cancer	5.69e-06	6.75e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ERCC2—prostate cancer	5.68e-06	6.74e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—TH—prostate cancer	5.62e-06	6.66e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CB—prostate cancer	5.61e-06	6.66e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SULT2A1—prostate cancer	5.61e-06	6.65e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTGS2—prostate cancer	5.56e-06	6.6e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP3A4—prostate cancer	5.56e-06	6.59e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTEN—prostate cancer	5.52e-06	6.55e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—MED12—prostate cancer	5.51e-06	6.54e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GNG5—prostate cancer	5.47e-06	6.49e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP1B1—prostate cancer	5.46e-06	6.48e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.43e-06	6.44e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ACSL4—prostate cancer	5.43e-06	6.44e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—MTHFR—prostate cancer	5.34e-06	6.34e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GGT1—prostate cancer	5.29e-06	6.28e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NCOA3—prostate cancer	5.27e-06	6.25e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—EP300—prostate cancer	5.27e-06	6.25e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PPARA—prostate cancer	5.24e-06	6.22e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NCOA1—prostate cancer	5.21e-06	6.18e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ARG2—prostate cancer	5.2e-06	6.17e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—UMPS—prostate cancer	5.2e-06	6.17e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PHGDH—prostate cancer	5.2e-06	6.17e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP19A1—prostate cancer	5.14e-06	6.09e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—LDHB—prostate cancer	5.1e-06	6.05e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—HPGDS—prostate cancer	5.03e-06	5.96e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP3A5—prostate cancer	5.01e-06	5.94e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP2C19—prostate cancer	5e-06	5.93e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—RXRA—prostate cancer	4.96e-06	5.88e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CAV1—prostate cancer	4.93e-06	5.84e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTT1—prostate cancer	4.88e-06	5.78e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ACHE—prostate cancer	4.88e-06	5.78e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTEN—prostate cancer	4.85e-06	5.76e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TCN2—prostate cancer	4.84e-06	5.74e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PDHA1—prostate cancer	4.84e-06	5.74e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—UCP3—prostate cancer	4.84e-06	5.74e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTA3—prostate cancer	4.84e-06	5.74e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP2A6—prostate cancer	4.82e-06	5.72e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—COMT—prostate cancer	4.78e-06	5.67e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTP1—prostate cancer	4.75e-06	5.64e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—AKR1C3—prostate cancer	4.69e-06	5.56e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ITPR1—prostate cancer	4.68e-06	5.55e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PRKACB—prostate cancer	4.66e-06	5.53e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—EP300—prostate cancer	4.63e-06	5.49e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP17A1—prostate cancer	4.62e-06	5.48e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.61e-06	5.47e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.61e-06	5.47e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CG—prostate cancer	4.49e-06	5.32e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.42e-06	5.25e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTA4—prostate cancer	4.42e-06	5.25e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—TYMS—prostate cancer	4.42e-06	5.24e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NCOA2—prostate cancer	4.4e-06	5.22e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTM1—prostate cancer	4.37e-06	5.18e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTA2—prostate cancer	4.31e-06	5.11e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—LPL—prostate cancer	4.29e-06	5.09e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ABCG5—prostate cancer	4.26e-06	5.05e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.26e-06	5.05e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—INS—prostate cancer	4.25e-06	5.04e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLC5A5—prostate cancer	4.2e-06	4.98e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CREBBP—prostate cancer	4.16e-06	4.94e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTA1—prostate cancer	4.16e-06	4.93e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP1A1—prostate cancer	4.14e-06	4.91e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.11e-06	4.88e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTO1—prostate cancer	4.11e-06	4.88e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NAT2—prostate cancer	4.11e-06	4.88e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ERCC2—prostate cancer	4.11e-06	4.87e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.1e-06	4.86e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NQO1—prostate cancer	4.05e-06	4.81e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TH—prostate cancer	3.99e-06	4.74e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP3A4—prostate cancer	3.95e-06	4.69e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CD—prostate cancer	3.94e-06	4.68e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.94e-06	4.68e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PLCB2—prostate cancer	3.94e-06	4.68e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—LRP2—prostate cancer	3.94e-06	4.68e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3CA—prostate cancer	3.9e-06	4.62e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP1B1—prostate cancer	3.89e-06	4.61e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—P4HB—prostate cancer	3.87e-06	4.59e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—MTHFR—prostate cancer	3.86e-06	4.58e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PPARA—prostate cancer	3.79e-06	4.49e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GGT1—prostate cancer	3.76e-06	4.46e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.76e-06	4.46e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NOS3—prostate cancer	3.72e-06	4.42e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NCOA1—prostate cancer	3.71e-06	4.4e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.66e-06	4.35e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP19A1—prostate cancer	3.65e-06	4.33e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—MED12—prostate cancer	3.61e-06	4.28e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GNG5—prostate cancer	3.58e-06	4.24e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CAV1—prostate cancer	3.56e-06	4.22e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—RXRA—prostate cancer	3.53e-06	4.18e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NCOA3—prostate cancer	3.45e-06	4.09e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CB—prostate cancer	3.44e-06	4.08e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CA—prostate cancer	3.42e-06	4.06e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTGS2—prostate cancer	3.41e-06	4.04e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—COMT—prostate cancer	3.4e-06	4.03e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTP1—prostate cancer	3.38e-06	4.01e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ITPR1—prostate cancer	3.33e-06	3.95e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HPGDS—prostate cancer	3.29e-06	3.9e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.27e-06	3.87e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CG—prostate cancer	3.24e-06	3.85e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ACHE—prostate cancer	3.19e-06	3.78e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTT1—prostate cancer	3.19e-06	3.78e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—AKT1—prostate cancer	3.18e-06	3.78e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.15e-06	3.74e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TYMS—prostate cancer	3.14e-06	3.73e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTM1—prostate cancer	3.11e-06	3.68e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—INS—prostate cancer	3.07e-06	3.64e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.07e-06	3.64e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PRKACB—prostate cancer	3.05e-06	3.62e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—LPL—prostate cancer	3.05e-06	3.62e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.02e-06	3.58e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CREBBP—prostate cancer	3.01e-06	3.57e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTEN—prostate cancer	2.97e-06	3.52e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.94e-06	3.49e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ERCC2—prostate cancer	2.92e-06	3.46e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NCOA2—prostate cancer	2.88e-06	3.41e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CD—prostate cancer	2.85e-06	3.38e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—EP300—prostate cancer	2.83e-06	3.36e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—AKT1—prostate cancer	2.8e-06	3.32e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—MTHFR—prostate cancer	2.75e-06	3.26e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.74e-06	3.25e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PPARA—prostate cancer	2.69e-06	3.19e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NOS3—prostate cancer	2.69e-06	3.19e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.68e-06	3.18e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NQO1—prostate cancer	2.65e-06	3.14e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TH—prostate cancer	2.61e-06	3.1e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.54e-06	3.01e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CAV1—prostate cancer	2.53e-06	3e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CB—prostate cancer	2.49e-06	2.95e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTGS2—prostate cancer	2.46e-06	2.92e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GGT1—prostate cancer	2.46e-06	2.92e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NCOA1—prostate cancer	2.42e-06	2.87e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.39e-06	2.83e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.31e-06	2.74e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—RXRA—prostate cancer	2.31e-06	2.73e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—COMT—prostate cancer	2.22e-06	2.63e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTP1—prostate cancer	2.21e-06	2.62e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—INS—prostate cancer	2.18e-06	2.59e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ITPR1—prostate cancer	2.17e-06	2.58e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTEN—prostate cancer	2.15e-06	2.55e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CREBBP—prostate cancer	2.14e-06	2.54e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CA—prostate cancer	2.1e-06	2.49e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TYMS—prostate cancer	2.05e-06	2.44e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—EP300—prostate cancer	2.05e-06	2.43e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTM1—prostate cancer	2.03e-06	2.41e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.03e-06	2.41e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—LPL—prostate cancer	1.99e-06	2.36e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.93e-06	2.28e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NOS3—prostate cancer	1.91e-06	2.27e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.91e-06	2.27e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.79e-06	2.13e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.77e-06	2.1e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PPARA—prostate cancer	1.76e-06	2.09e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.75e-06	2.08e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—AKT1—prostate cancer	1.71e-06	2.03e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CAV1—prostate cancer	1.66e-06	1.96e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTEN—prostate cancer	1.53e-06	1.81e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.52e-06	1.8e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.51e-06	1.79e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—EP300—prostate cancer	1.46e-06	1.73e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—INS—prostate cancer	1.43e-06	1.69e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.4e-06	1.66e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.33e-06	1.57e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NOS3—prostate cancer	1.25e-06	1.48e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—AKT1—prostate cancer	1.24e-06	1.47e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.16e-06	1.37e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.14e-06	1.36e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.08e-06	1.28e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTEN—prostate cancer	9.98e-07	1.18e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—EP300—prostate cancer	9.52e-07	1.13e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—AKT1—prostate cancer	8.8e-07	1.04e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.04e-07	8.36e-06	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—AKT1—prostate cancer	5.75e-07	6.83e-06	CbGpPWpGaD
